Purchase Order HHSN263201700340A
Award Date 6/22/17
Potential Completion Date 7/7/17
Potential Value $179K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $197,925.00 firm fixed price purchase order for an Illumina NextSeq Sequencing System to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The purchase order was not set aside for any specific business size or type. The award is intended to support the agency's mission by providing a sequencing platform that can increase data output...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $224,400.00 firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The award is for the provision of a NextSeq 550 Sequencing System with a trade-in of a HiSeq 500 system. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Firm Fixed Price purchase order to Illumina, Inc., a manufacturer of genetic sequencing systems and related products, for the delivery of an Illumina NextSeq 550 Sequencing System. The potential value of the award is $224,400.00. No set-aside provisions were used. The award was made under a special notice solicitation for an Illumina HiSeq 2500 Sequencer. Illumina has...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the purchase of NextSeq, MiSeq, and iSeq sequencing kits. The $96,390.00 award does not have a set-aside designation and is intended to support genomic research and analysis at the agency's Bethesda, MD location. Illumina has...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Environmental Health Sciences awarded a $60,192.34 firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The contract, which does not have a set-aside designation, is to provide sequencing systems, consumables, and support for NIH genomic research and diagnostics. This award appears to be under a larger...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. to provide an Illumina NextSeq 550 sequencing system. The potential value of the contract is $273,655.08. There was no set-aside designation for this award. Illumina, a for-profit manufacturer of genetic and genomic analysis instruments and reagents, has provided a range of sequencing systems and related...
- This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit organization and manufacturer of sequencing and genomic analysis solutions. The contract, valued at $112,216.00, is for the purchase of Illumina's sequencing systems, reagents, and other products to support genomic research and diagnostics. The contract is a firm fixed price purchase order with no set-aside designation....
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and related products, to provide a NextSeq 2000 sequencing system. The potential value of the contract is $290,700.00. There was no set-aside designation for this award. Illumina has previously received prime contract awards from federal agencies like the National...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The $3,504.92 award is for the provision of sequencing systems, reagents, and related services to support genomic research and diagnostics. Illumina has a history of providing these types of goods and services to federal...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The $145,808.65 award is for the provision of Illumina's proprietary NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated consumables and support services. This award is not...